Joseph Mortimer

Joseph Mortimer has a diverse work experience in the field of scientific research. Joseph currently works at Xap Therapeutics, where they hold the position of Principal Scientist since December 2022. Prior to this, they worked as a Senior Scientist at the same company from July 2021 to December 2022.

Before joining Xap Therapeutics, Joseph worked at GSK for several years. Joseph started their career at GSK as an Industrial Placement Student from September 2014 to September 2015. Joseph then progressed to the role of Cell Biologist from October 2016 to September 2017. Subsequently, they took on the position of Senior Scientist from September 2017 to October 2019. Finally, they served as a Scientific Investigator from October 2019 to July 2021.

Overall, Joseph has a strong background in scientific research, with experience in various roles at both Xap Therapeutics and GSK.

Joseph Mortimer attended the University of Kent from 2012 to 2016 and obtained a Bachelor's Degree in Biochemistry with a year in Industry.